Prescient Therapeutics (ASX: PTX) – Webinar Presentation
Steven Yatomi-Clarke – CEO & MD – Prescient Therapeutics is focused on developing novel, personalised...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO Steven Yatomi-Clarke and Director of Scientific Affairs, Rebecca...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO Steven Yatomi-Clarke is joined by special guest Professor...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO Steven Yatomi-Clarke is joined by special guests Professor...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO and MD Steven Yatomi-Clarke and Senior VP of...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO Steven Yatomi-Clarke provides an in-depth look at the...
Shares of Mirati Therapeutics jumped after the company announced its first clinical cancer drug results....
To stay up to date with Prescient Therapeutics news and events, please register your details.